The development of long-acting drug depots represents a significant advancement in pharmaceutical technology, offering ...

Liquidia Corporation (NASDAQ: LQDA), a biopharmaceutical company developing innovative therapies for patients with rare cardiopulmonary disease, today announced that the U.S. Food and Drug ...

eliminating the need for frequent drug injections. This approach could prove useful for delivering long-lasting ...

MIT engineers have developed a new drug delivery method that could change long-term treatments with fewer injections and less ...

LAHORE (Dunya News) - A drug testing lab has declared that the injection used for lung patients at Surgical Chest Ward of ...

THE Food and Drug Administration (FDA) on Friday, March 21, 2025, warned the public against the presence of counterfeit ...

has accepted its New Drug Application (NDA) resubmission for YUTREPIA™ (treprostinil) inhalation powder to treat pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with ...